153 related articles for article (PubMed ID: 37180502)
1. GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy.
Jemelkova J; Stuchlova Horynova M; Kosztyu P; Zachova K; Zadrazil J; Galuszkova D; Takahashi K; Novak J; Raska M
Kidney Int Rep; 2023 May; 8(5):1068-1075. PubMed ID: 37180502
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Reily C; Rice T; Crossman DK; Rizk DV
J Autoimmun; 2022 Oct; 132():102883. PubMed ID: 35987175
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
4. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
5. Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.
Yamada K; Huang ZQ; Raska M; Reily C; Anderson JC; Suzuki H; Kiryluk K; Gharavi AG; Julian BA; Willey CD; Novak J
Kidney Dis (Basel); 2020 May; 6(3):168-180. PubMed ID: 32523959
[TBL] [Abstract][Full Text] [Related]
6. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
[TBL] [Abstract][Full Text] [Related]
7. Racial heterogeneity of IgA1 hinge-region
Ohyama Y; Yamaguchi H; Ogata S; Chiurlia S; Cox SN; Kouri NM; Stangou MJ; Nakajima K; Hayashi H; Inaguma D; Hasegawa M; Yuzawa Y; Tsuboi N; Renfrow MB; Novak J; Papagianni AA; Schena FP; Takahashi K
iScience; 2022 Nov; 25(11):105223. PubMed ID: 36277451
[TBL] [Abstract][Full Text] [Related]
8. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.
Yu G; Zhang Y; Meng B; Xie X; Wang Z; Ying W; Lv J; Zhang H
Nephrol Dial Transplant; 2021 Dec; 37(1):33-41. PubMed ID: 34152412
[TBL] [Abstract][Full Text] [Related]
9. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
10. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
11. LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy.
Yamada K; Huang ZQ; Reily C; Green TJ; Suzuki H; Novak J; Suzuki Y
Kidney Int Rep; 2024 Feb; 9(2):423-435. PubMed ID: 38344714
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.
Yamada K; Huang ZQ; Raska M; Reily C; Anderson JC; Suzuki H; Ueda H; Moldoveanu Z; Kiryluk K; Suzuki Y; Wyatt RJ; Tomino Y; Gharavi AG; Weinmann A; Julian BA; Willey CD; Novak J
Kidney Int Rep; 2017 Nov; 2(6):1194-1207. PubMed ID: 29270528
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
Liang Y; Zeng Q; Wang XH; Yan L; Yu RH
Biomed Res Int; 2023; 2023():5124034. PubMed ID: 36660452
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants.
Zhang S; Sun H; Zhang Z; Li M; Guo Z; Ye W; Cai G; Sun W; Li M
Front Mol Biosci; 2022; 9():871615. PubMed ID: 35445079
[No Abstract] [Full Text] [Related]
15. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
16. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
Suzuki H; Moldoveanu Z; Julian BA; Wyatt RJ; Novak J
Kidney Int Rep; 2019 Dec; 4(12):1717-1724. PubMed ID: 31844808
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
20. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
Yamasaki K; Suzuki H; Yasutake J; Yamazaki Y; Suzuki Y
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
